Page last updated: 2024-10-16

gamma-aminobutyric acid and Retinoblastoma

gamma-aminobutyric acid has been researched along with Retinoblastoma in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Retinoblastoma: A malignant tumor arising from the nuclear layer of the retina that is the most common primary tumor of the eye in children. The tumor tends to occur in early childhood or infancy and may be present at birth. The majority are sporadic, but the condition may be transmitted as an autosomal dominant trait. Histologic features include dense cellularity, small round polygonal cells, and areas of calcification and necrosis. An abnormal pupil reflex (leukokoria); NYSTAGMUS, PATHOLOGIC; STRABISMUS; and visual loss represent common clinical characteristics of this condition. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2104)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Madtes, P1
Kyritsis, A1
Chader, GJ1

Other Studies

1 other study available for gamma-aminobutyric acid and Retinoblastoma

ArticleYear
Neurotransmitter systems in morphologically undifferentiated human Y-79 retinoblastoma cells: studies of GABAergic, glycinergic, and beta-adrenergic systems.
    Journal of neurochemistry, 1985, Volume: 45, Issue:6

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cell Line; Cyclic AMP; Eye Neoplasms

1985